Drug Type Small molecule drug |
Synonyms |
Target- |
Mechanism kinase inhibitor |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC12H13F3N8 |
InChIKeyBMQUGSZRQKPRTR-UHFFFAOYSA-N |
CAS Registry2571586-16-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Infection by Trypanosoma brucei brucei | Preclinical | US | 13 Aug 2020 | |
Infection by Trypanosoma brucei brucei | Preclinical | ES | 13 Aug 2020 |